FIELD: medicine.
SUBSTANCE: invention relates to virology, immunology and medicine. The composition contains antigen bound or fused with virus-like particle (VLP), completed with immunostimulating nucleic acid containing at least one unmathylated CpG-sequence and ligand of toll-like receptor (TLR). There are also disclosed vaccine composition and method for potentiating immune response in an animal.
EFFECT: invention can be used for inducing strong antibody and T-cell response and, particularly it is effective in treatment of allergy, tumours and virus chronic diseases, and also other chronic diseases.
25 cl, 12 dwg, 1 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS COMPRISING CpG-OLIGONUCLEOTIDES AND VIRUS-LIKE PARTICLES FOR USING AS ADJUVANTS | 2003 |
|
RU2322257C2 |
| CONJUGATES OF PEPTIDE Melan-A, VIRUS-LIKE PARTICLE ANALOGUE | 2004 |
|
RU2351362C2 |
| MODIFIED VIRUS PARTICLES OF CUCUMBER MOSAIC VIRUS | 2015 |
|
RU2706970C2 |
| PARTICLES PACKED IN IMMUNOSTIMULATING NUCLEIC ACID THAT INTENDED FOR HYPERSENSITIVITY TREATMENT | 2006 |
|
RU2451523C2 |
| PCSK9 VACCINE | 2010 |
|
RU2538162C2 |
| VIRUS-LIKE PARTICLES INCLUDING HYBRID PROTEIN OF AP205 BACTERIOPHAGE COAT PROTEIN AND ANTIGEN POLYPEPTIDE | 2005 |
|
RU2409667C2 |
| ANTIGEN MOLECULAR MASSIFS | 2003 |
|
RU2324704C2 |
| CAT ALLERGEN FUSED PROTEIN AND APPLICATION THEREOF | 2006 |
|
RU2414239C2 |
| CH3 IGE PEPTIDE VACCINE | 2009 |
|
RU2495049C2 |
| COMPOSITION FOR IMMUNIZATION (VARIANTS), METHOD FOR ITS PREPARING AND USING FOR TREATMENT OF ALLERGIC EOSINOPHILIC DISEASES | 2002 |
|
RU2319503C2 |
